Perioperative discontinuation of antiplatelet therapy of patients with coronary stents : RReevaluating the risks Perioperatives Pausieren der antithrombozytären Therapie bei Patienten mit koronaren Stents : Ein neu zu bewertendes Risiko?
Graw J, Schwenk W, Volk T (2009)
Publication Type: Journal article
Publication year: 2009
Journal
Book Volume: 80
Pages Range: 498-501
Journal Issue: 6
DOI: 10.1007/s00104-008-1642-3
Abstract
According to the present guidelines, patients with coronary stents are to be treated with dual antiplatelet therapy. In case surgery is needed, the risk of a fatal stent thrombosis by withdrawing antithrombotics needs to be balanced in each individual case against the risk of haemorrhagic complications on continued antiplatelet medication. We present a case of fatal stent thrombosis and discuss the current evidence regarding perioperative continuation and interruption of antiplatelet therapy for this patient population. In summary the haemorrhagic risk with acetylsalicylic acid for secondary prevention seems very low, and it should be discontinued only in selected cases. Continued dual anticoagulation concepts are also discussed. © 2008 Springer Medizin Verlag.
Involved external institutions
Germany (DE)How to cite
APA:
Graw, J., Schwenk, W., & Volk, T. (2009). Perioperative discontinuation of antiplatelet therapy of patients with coronary stents : RReevaluating the risks Perioperatives Pausieren der antithrombozytären Therapie bei Patienten mit koronaren Stents : Ein neu zu bewertendes Risiko? Chirurg, 80(6), 498-501. https://doi.org/10.1007/s00104-008-1642-3
MLA:
Graw, J., W. Schwenk, and T. Volk. "Perioperative discontinuation of antiplatelet therapy of patients with coronary stents : RReevaluating the risks Perioperatives Pausieren der antithrombozytären Therapie bei Patienten mit koronaren Stents : Ein neu zu bewertendes Risiko?" Chirurg 80.6 (2009): 498-501.
BibTeX: Download